跳至主要内容
临床试验/NL-OMON44849
NL-OMON44849招募中不适用

Organ motion and early tumor response measurement during chemoradiotherapy for esophageal cancer. - Organ motion and early tumor response measurement

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Histologic evidence of invasive adenocarcinoma or squamous cell cancer of the esophagus
  • Patient eligible for trimodality treatment (chemoradiotherapy and surgery) or definitive chemoradiotherapy
  • T3N0M0 or T1-4N1-3M0. Patients with M1 disease solely on the basis of supraclavicular metastasis and not a junction tumor as primary are eligible. (AJCC 7th edition)
  • WHO performance status <= 2
  • Clinically operable for R0 resection in the opinion of an experienced upper gastrointestinal or thoracic surgeon for patients planned for trimodality
  • Tumor localization at least 2cm from the upper esophageal sphincter and invading no more than 5cm into gastric cardia
  • • Age >= 18 years
  • Written informed consent before endoscopy or EUS

排除标准

  • Prior treatment with thoracic surgery or thoracic radiotherapy
  • Pregnancy
  • Severe cardiopulmonary restriction

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验